<VariationArchive VariationID="372403" VariationName="NM_000228.3(LAMB3):c.2842del (p.Val948fs)" VariationType="Deletion" Accession="VCV000372403" Version="13" RecordType="classified" NumberOfSubmissions="6" NumberOfSubmitters="6" DateLastUpdated="2024-06-10" DateCreated="2017-01-09" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="359293" VariationID="372403">
      <GeneList>
        <Gene Symbol="LAMB3" FullName="laminin subunit beta 3" GeneID="3914" HGNC_ID="HGNC:6490" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209614870" stop="209652425" display_start="209614870" display_stop="209652425" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209788214" stop="209825819" display_start="209788214" display_stop="209825819" Strand="-" />
          </Location>
          <OMIM>150310</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000228.3(LAMB3):c.2842del (p.Val948fs)</Name>
      <CanonicalSPDI>NC_000001.11:209618518:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209618519" stop="209618519" display_start="209618519" display_stop="209618519" variantLength="1" positionVCF="209618518" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209791864" stop="209791864" display_start="209791864" display_stop="209791864" variantLength="1" positionVCF="209791863" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>V948fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.209791865del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.209791865del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.209618520del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.209618520del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007116.1" sequenceAccession="NG_007116" sequenceVersion="1" change="g.38957del">
            <Expression>NG_007116.1:g.38957del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000228.3" sequenceAccession="NM_000228" sequenceVersion="3" change="c.2842del" MANESelect="true">
            <Expression>NM_000228.3:c.2842del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000219.2" sequenceAccession="NP_000219" sequenceVersion="2" change="p.Val948fs">
            <Expression>NP_000219.2:p.Val948fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001017402.2" sequenceAccession="NM_001017402" sequenceVersion="2" change="c.2842del">
            <Expression>NM_001017402.2:c.2842del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001017402.1" sequenceAccession="NP_001017402" sequenceVersion="1" change="p.Val948fs">
            <Expression>NP_001017402.1:p.Val948fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127641.1" sequenceAccession="NM_001127641" sequenceVersion="1" change="c.2842del">
            <Expression>NM_001127641.1:c.2842del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121113.1" sequenceAccession="NP_001121113" sequenceVersion="1" change="p.Val948fs">
            <Expression>NP_001121113.1:p.Val948fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA1375081" DB="ClinGen" />
        <XRef Type="rs" ID="772421306" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000228.3(LAMB3):c.2842del (p.Val948fs) AND not provided" Accession="RCV000413231" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-22" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000228.3(LAMB3):c.2842del (p.Val948fs) AND Junctional epidermolysis bullosa gravis of Herlitz" Accession="RCV000984194" Version="2">
        <ClassifiedConditionList TraitSetID="2421">
          <ClassifiedCondition DB="MedGen" ID="C0079683">Junctional epidermolysis bullosa gravis of Herlitz</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000228.3(LAMB3):c.2842del (p.Val948fs) AND Junctional epidermolysis bullosa, non-Herlitz type" Accession="RCV000780371" Version="1">
        <ClassifiedConditionList TraitSetID="2422">
          <ClassifiedCondition DB="MedGen" ID="C0268374">Junctional epidermolysis bullosa, non-Herlitz type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-11-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000228.3(LAMB3):c.2842del (p.Val948fs) AND multiple conditions" Accession="RCV002481270" Version="1">
        <ClassifiedConditionList TraitSetID="26562">
          <ClassifiedCondition DB="MedGen" ID="C4011403">Amelogenesis imperfecta type 1A</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0079683">Junctional epidermolysis bullosa gravis of Herlitz</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268374">Junctional epidermolysis bullosa, non-Herlitz type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-22" NumberOfSubmissions="6" NumberOfSubmitters="6" DateCreated="2017-01-09" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11023379</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16473856</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23278291</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="26562" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5022" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, Herlitz-Pearson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-Pearson type epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Letalis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa gravis of Herlitz</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Letalis/2580" DB="Genetic Alliance" />
                <XRef ID="400140006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-type junctional epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JEB-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2153" />
                <XRef ID="2153" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <XRef ID="79404" DB="Orphanet" />
              <XRef ID="C0079683" DB="MedGen" />
              <XRef ID="MONDO:0009182" DB="MONDO" />
              <XRef Type="MIM" ID="226700" DB="OMIM" />
            </Trait>
            <Trait ID="5023" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa, non-Herlitz type</ElementValue>
                <XRef ID="MONDO:0009180" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adult junctional epidermolysis bullosa</ElementValue>
                <XRef ID="33662006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, non-herlitz type, somatic mosaic revertant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2151" />
                <XRef ID="2151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="251393" DB="Orphanet" />
              <XRef ID="79402" DB="Orphanet" />
              <XRef ID="79405" DB="Orphanet" />
              <XRef ID="89840" DB="Orphanet" />
              <XRef ID="C0268374" DB="MedGen" />
              <XRef ID="MONDO:0009180" DB="MONDO" />
              <XRef Type="MIM" ID="226650" DB="OMIM" />
            </Trait>
            <Trait ID="389" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Amelogenesis imperfecta type 1A</ElementValue>
                <XRef ID="MONDO:0007094" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amelogenesis imperfecta local hypoplastic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amelogenesis imperfecta, hypoplastic type</ElementValue>
                <XRef ID="109476006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amelogenesis imperfecta, type IA</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE IA</ElementValue>
                <XRef Type="MIM" ID="104530" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AI1A</ElementValue>
                <XRef Type="MIM" ID="104530" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15038" />
                <XRef ID="15038" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="88661" DB="Orphanet" />
              <XRef ID="C4011403" DB="MedGen" />
              <XRef ID="MONDO:0007094" DB="MONDO" />
              <XRef Type="MIM" ID="104530" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2421" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5022" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, Herlitz-Pearson type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-Pearson type epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis Bullosa Letalis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa gravis of Herlitz</ElementValue>
                <XRef ID="Epidermolysis+Bullosa+Letalis/2580" DB="Genetic Alliance" />
                <XRef ID="400140006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Herlitz-type junctional epidermolysis bullosa</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">JEB-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226700" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2153" />
                <XRef ID="2153" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <XRef ID="79404" DB="Orphanet" />
              <XRef ID="C0079683" DB="MedGen" />
              <XRef ID="MONDO:0009182" DB="MONDO" />
              <XRef Type="MIM" ID="226700" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2422" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5023" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa, non-Herlitz type</ElementValue>
                <XRef ID="MONDO:0009180" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adult junctional epidermolysis bullosa</ElementValue>
                <XRef ID="33662006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, non-herlitz type, somatic mosaic revertant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2151" />
                <XRef ID="2151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="251393" DB="Orphanet" />
              <XRef ID="79402" DB="Orphanet" />
              <XRef ID="79405" DB="Orphanet" />
              <XRef ID="89840" DB="Orphanet" />
              <XRef ID="C0268374" DB="MedGen" />
              <XRef ID="MONDO:0009180" DB="MONDO" />
              <XRef Type="MIM" ID="226650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="958081" SubmissionDate="2019-01-29" DateLastUpdated="2017-01-09" DateCreated="2017-01-09">
        <ClinVarSubmissionID localKey="GDX:30515|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000490597" DateUpdated="2017-01-09" DateCreated="2017-01-09" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2842delG pathogenic variant in the LAMB3 gene has been reported previously in thehomozygous or compound heterozygous state in patients with Herlitz JEB (Varki et al., 2006;Kittridge et al., 2014). The deletion causes a frameshift starting with codon Valine 948, changes this amino acid to a Cysteine residue and creates a premature Stop codon at position 82 of the new reading frame, denoted p.Val948CysfsX82. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. In addition, the c.2842delG variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. We interpret c.2842delG as a pathogenic variant.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000228.2:c.2842delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1794186" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_000228.2:c.2842delG|MedGen:C0268374" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000917570" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23278291</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>Variant summary: LAMB3 c.2842delG (p.Val948CysfsX82) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.8e-05 in 277164 control chromosomes (gnomAD). The variant, c.2842delG, has been reported in the literature in individuals affected with Herlitz Junctional Epidermolysis Bullosa (Kittridge_2014, Varki_2006). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000228.2:c.2842delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Adult junctional epidermolysis bullosa</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0268374" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2235320" SubmissionDate="2019-08-05" DateLastUpdated="2019-12-23" DateCreated="2019-12-23">
        <ClinVarSubmissionID localKey="23679|OMIM:226700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001132245" DateUpdated="2019-12-23" DateCreated="2019-12-23" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-03-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23278291</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="A" referenceAllele="AC" start="209791863" stop="209791864" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2291927" SubmissionDate="2019-09-27" DateLastUpdated="2020-02-29" DateCreated="2020-02-29">
        <ClinVarSubmissionID localKey="NC_000001.10:g.209791865delC|OMIM:226700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001162871" DateUpdated="2020-02-29" DateCreated="2020-02-29" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.209791865delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1832465" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2783595|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000938577" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11023379</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16473856</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Val948Cysfs*82) in the LAMB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LAMB3 are known to be pathogenic (PMID: 11023379, 16473856). This variant is present in population databases (rs772421306, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with Herlitz junctional epidermolysis bullosa (PMID: 16473856). ClinVar contains an entry for this variant (Variation ID: 372403). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.209791864del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5426711" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000228.3:c.2842del|OMIM:104530;226650;226700" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002780325" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000228.3:c.2842del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="104530" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226650" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="226700" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2235320" TraitType="Disease" MappingType="XRef" MappingValue="226700" MappingRef="OMIM">
        <MedGen CUI="C0079683" Name="Junctional epidermolysis bullosa gravis of Herlitz" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426711" TraitType="Disease" MappingType="XRef" MappingValue="104530" MappingRef="OMIM">
        <MedGen CUI="C4011403" Name="Amelogenesis imperfecta type 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1832465" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="958081" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426711" TraitType="Disease" MappingType="XRef" MappingValue="226700" MappingRef="OMIM">
        <MedGen CUI="C0079683" Name="Junctional epidermolysis bullosa gravis of Herlitz" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1794186" TraitType="Disease" MappingType="Name" MappingValue="Adult junctional epidermolysis bullosa" MappingRef="Preferred">
        <MedGen CUI="C0268374" Name="Junctional epidermolysis bullosa, non-Herlitz type" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2291927" TraitType="Disease" MappingType="XRef" MappingValue="226700" MappingRef="OMIM">
        <MedGen CUI="C0079683" Name="Junctional epidermolysis bullosa gravis of Herlitz" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5426711" TraitType="Disease" MappingType="XRef" MappingValue="226650" MappingRef="OMIM">
        <MedGen CUI="C0268374" Name="Junctional epidermolysis bullosa, non-Herlitz type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

